MFDS — authorised 20 February 1953
- Marketing authorisation holder: HOSPIRA
- Status: likely_approved
🇰🇷 Infuvite Pediatric in South Korea
MFDS authorised Infuvite Pediatric on 20 February 1953
Marketing authorisation
Infuvite Pediatric in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Infuvite Pediatric approved in South Korea?
Yes. MFDS authorised it on 20 February 1953.
Who is the marketing authorisation holder for Infuvite Pediatric in South Korea?
HOSPIRA holds the South Korean marketing authorisation.